Journal article

Prevention of nosocomial transmission of hepatitis B virus (HBV) and hepatitis C virus (HCV) by healthcare workers. Recommendations of the German Association for the Control of Viral Diseases (DVV) e.V.


Authors listGlebe, Dieter; van Boemmel, Florian; Dudareva, Sandra; Gaertner, Barbara; Monazahian, Masyar; Ross, Stefan; Roesler, Joachim; Slanina, Heiko; Spickhoff, Andreas; Thanheiser, Marc; Schuettlerl, Christian G.

Publication year2020

Pages218-225

JournalBundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz

Volume number63

Issue number2

ISSN1436-9990

eISSN1437-1588

DOI Linkhttps://doi.org/10.1007/s00103-019-03084-9

PublisherSpringer


Abstract
The German Association for the Control of Viral Diseases (DVV) e.V. provides updated recommendations for the deployment of health care workers who have a hepatitis B virus (HBV) and/or hepatitis C virus (HCV) infection. The prevention of nosocomial infections remains the primary objective of the recommendations. In addition to patient protection, the professional and social interests of employees in the health care system were also taken into account. The risk of transmission from infected medical personnel to others is determined by the level of viremia and the type of work performed, must be assessed on a case-by-case basis and can range from negligible to high. The following conditions apply: serological HBV genome concentrations of less than 200 IU/mL and/or HCV genome equivalents of less than 250 IU/mL do not restrict activities with a high risk of transmission, provided that general and special hygiene measures are adhered to (e.g. continuous occupational health care, wearing of double gloves, serological follow-up under detectable viremia, utilization of antiviral therapy options). HBV genome concentrations exceeding 20,000 IU/mL and/or HCV genome equivalents exceeding 25,000 IU/mL and HBV/HCV infections in the acute clinical phase are incompatible with the performance of activities with transmission potential. However, the return to high transmission activities after successful antiviral therapy should be limited for HBV with stable serological status of 200 to 20,000 IU/mL and for HCV of 250 to 25,000 IU/mL.



Citation Styles

Harvard Citation styleGlebe, D., van Boemmel, F., Dudareva, S., Gaertner, B., Monazahian, M., Ross, S., et al. (2020) Prevention of nosocomial transmission of hepatitis B virus (HBV) and hepatitis C virus (HCV) by healthcare workers. Recommendations of the German Association for the Control of Viral Diseases (DVV) e.V., Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, 63(2), pp. 218-225. https://doi.org/10.1007/s00103-019-03084-9

APA Citation styleGlebe, D., van Boemmel, F., Dudareva, S., Gaertner, B., Monazahian, M., Ross, S., Roesler, J., Slanina, H., Spickhoff, A., Thanheiser, M., & Schuettlerl, C. (2020). Prevention of nosocomial transmission of hepatitis B virus (HBV) and hepatitis C virus (HCV) by healthcare workers. Recommendations of the German Association for the Control of Viral Diseases (DVV) e.V.. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 63(2), 218-225. https://doi.org/10.1007/s00103-019-03084-9



Keywords


GUIDELINEHepatitis CHIVNosocomial HBV and HCV infectionTransmission risk

Last updated on 2025-21-05 at 18:24